Abstract
Background: To facilitate translational drug development for liver fibrosis, preclinical trials need to be run in parallel with clinical research. Liver function estimation by gadoxetate-enhanced dynamic contrast-enhanced MRI (DCE-MRI) is being established in clinical research, but still rarely used in preclinical trials. We aimed to evaluate feasibility of DCE-MRI indices as translatable biomarkers in a liver fibrosis animal model. Methods: Liver fibrosis was induced in Sprague-Dawley rats by thioacetamide (200 mg, 150 mg, and saline for the high-dose, low-dose, and control groups, respectively). Subsequently, DCE-MRI was performed to measure: Relative liver enhancement at 3-min (RLE-3), RLE-15, initial area-under-the-curve until 3-min (iAUC-3), iAUC-15, and maximum-enhancement (Emax). The correlation coefficients between these MRI indices and the histologic collagen area, indocyanine green retention at 15-min (ICG-R15), and shear wave elastography (SWE) were calculated. Diagnostic performance to diagnose liver fibrosis was also evaluated by receiver-operating-characteristic (ROC) analysis. Results: Animal model was successful in that the collagen area of the liver was the largest in the high-dose group, followed by the low-dose group and control group. The correlation between the DCE-MRI indices and collagen area was high for iAUC-15, Emax, iAUC-3, and RLE-3 but moderate for RLE-15 (r,-0.81,-0.81,-0.78,-0.80, and-0.51, respectively). The DCE-MRI indices showed moderate correlation with ICG-R15: The highest for iAUC-15, followed by iAUC-3, RLE-3, Emax, and RLE-15 (r,-0.65,-0.63,-0.62,-0.58, and-0.56, respectively). The correlation coefficients between DCE-MRI indices and SWE ranged from-0.59 to-0.28. The diagnostic accuracy of RLE-3, iAUC-3, iAUC-15, and Emax was 100% (AUROC 1.000), whereas those of RLE-15 and SWE were relatively low (AUROC 0.777, 0.848, respectively). Conclusion: Among the gadoxetate-enhanced DCE-MRI indices, iAUC-15 and iAUC-3 might be bidirectional translatable biomarkers between preclinical and clinical research for evaluating histopathologic liver fibrosis and physiologic liver functions in a non-invasive manner.
| Original language | English |
|---|---|
| Article number | 89 |
| Journal | BMC Medical Imaging |
| Volume | 19 |
| Issue number | 1 |
| DOIs | |
| State | Published - 15 Nov 2019 |
Bibliographical note
Publisher Copyright:© 2019 The Author(s).
Keywords
- Dynamic contrast-enhanced
- Gadoxetate
- Liver fibrosis
- Liver function
- Magnetic resonance imaging
Fingerprint
Dive into the research topics of 'Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver